ArticlePloS one2025
Mitosis detection in histopathological images using customized deep learning and hybrid optimization algorithms.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying mitosis is crucial for cancer diagnosis, but accurate detection remains difficult because of class imbalance and complex morphological variations in histopathological images. To overcome this challenge, we propose a Customized Deep Learning (CDL) model, which integrates advanced deep-learning techniques for better mitosis detection. The CDL model utilizes transfer learning to counter the effects of class imbalance and speed up convergence, while skip connections are also employed to improve the localization of mitosis. Furthermore, we have established an innovative selection mechanism by the hybrid of Jellyfish Search Optimizer (JSO) and Walrus Optimization Algorithm (WOA) to maximize the momentum of the model. The proposed approach is rigorously evaluated on multiple publicly available mitosis detection datasets, including Mitosis WSI CCMCT Training Set, Mitosis-AIC, Mitosis Detection, and Mitosis and Non-Mitosis datasets. To tackle these issues, we hereby bring forth a specifically tailored Custom Deep Learning model, that assimilates hybrid CNN architecture into transfer learning and feature selection for improved mitotic detection. The CDL model comprises a Transfer Learning-based Mitosis Detection module under which extracted features from pre-trained deep networks are used to bolster feature extraction and alleviate class imbalance through skip connections to better localize mitosis. The robust assessment on a benchmark dataset displays the outstanding efficacy of the CDL model, reaching an excellent F1 score of 0.994 and accuracy of 98.8% thus proving its strength for the detection of mitotic figures. This proposed methodology can greatly empower pathologists for accurate appraisal of cancer diagnosis and prognosis. Future lines of exploration will include fusion methodologies and time efficiency for real-time applications, as well as extending CDL to various histopathological analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.